Skip to main content
Equibles

SEI INVESTMENTS CO

Position in AKBA — Akebia Therapeutics, Inc.

CIK 350894 OAKS, PA
Back to AKBA Full portfolio

Position in AKBA

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$84,796
+$15,388 QoQ
Shares Held
74,383
+49.0% QoQ
Ownership
0.027%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#75
of 170 holders
Holding Since
Mar 2020
10 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in AKBA Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

SEI INVESTMENTS CO holds $374,044,345 across 37 Drug Manufacturers - Specialty & Generic names. AKBA ranks #35 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ELAN
Elanco Animal Health Inc
 5,284,773 $130,058,261
2 VTRS
Viatris Inc
 3,165,469 $50,267,647
3 TEVA
Teva Pharmaceutical Industries Ltd
 1,105,005 $37,437,568
4 NBIX
Neurocrine Biosciences Inc
 185,545 $31,271,754
5 ZTS
Zoetis Inc.
 237,394 $17,059,132
6 KNSA
Kiniksa Pharmaceuticals International, plc
 188,565 $12,058,731
7 AMRX
Amneal Pharmaceuticals, Inc.
 690,897 $11,959,425
8 LNTH
Lantheus Holdings, Inc.
 98,305 $10,905,956

All Filings in AKBA

Export CSV
10 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $84,796 74,383
2026-03-31 $69,408 49,934
2025-12-31 $80,393 49,934
2025-09-30 $154,245 56,500
2025-06-30 $696,131 191,245
2025-03-31 $336,086 175,045
2020-12-31 $39,846 14,231
2020-09-30 $39,245 15,636
2020-06-30 $676,500 49,816
2020-03-31 $99,214 13,089